These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 22432744)

  • 1. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation.
    Ajamieh H; Farrell GC; McCuskey RS; Yu J; Chu E; Wong HJ; Lam W; Teoh NC
    Liver Int; 2015 Sep; 35(9):2174-86. PubMed ID: 25786512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury.
    Teoh NC; Williams J; Hartley J; Yu J; McCuskey RS; Farrell GC
    Hepatology; 2010 Mar; 51(3):996-1006. PubMed ID: 20131406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
    Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
    Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing organ pool by statins: is this the future?
    Gracia-Sancho J
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1259-60. PubMed ID: 22823912
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.
    Ke B; Shen XD; Tsuchihashi S; Gao F; Araujo JA; Busuttil RW; Ritter T; Kupiec-Weglinski JW
    Hum Gene Ther; 2007 Apr; 18(4):355-66. PubMed ID: 17439357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
    J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway.
    Sano T; Izuishi K; Hossain MA; Inoue T; Kakinoki K; Hagiike M; Okano K; Masaki T; Suzuki Y
    Transplantation; 2011 May; 91(10):1082-9. PubMed ID: 21403587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.
    Laufs U; Gertz K; Huang P; Nickenig G; Böhm M; Dirnagl U; Endres M
    Stroke; 2000 Oct; 31(10):2442-9. PubMed ID: 11022078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
    Gao Y; Song LX; Jiang MN; Ge GY; Jia YJ
    Inflammation; 2008 Apr; 31(2):121-32. PubMed ID: 18302012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase.
    Ni R; Peleg T; Gross PL
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2609-15. PubMed ID: 22995523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats.
    Ozacmak VH; Sayan H; Igdem AA; Cetin A; Ozacmak ID
    Eur J Pharmacol; 2007 May; 562(1-2):138-47. PubMed ID: 17335801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts.
    Kim K; Jung N; Lee K; Choi J; Kim S; Jun J; Kim E; Kim D
    Clin Nutr; 2013 Oct; 32(5):855-62. PubMed ID: 23395256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH; Schwabe O; Hecker M
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice.
    Kuboki S; Schuster R; Blanchard J; Pritts TA; Wong HR; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1141-9. PubMed ID: 17185630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A.
    Shen KP; Lin HL; Chang WT; An LM; Chen IJ; Wu BN
    J Pharm Pharmacol; 2011 Jun; 63(6):860-8. PubMed ID: 21585385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.